Charlotte Schubert is a freelance science journalist based in Seattle with previous staff experience at Nature Medicine and at the Milwaukee Journal Sentinel. She has written for Nature, Proceedings of the National Academy of Sciences, Cell Press and other publications. She has Ph.D. from the University of Washington and just completed a year-long stint in an epigenetics lab at Fred Hutchinson Cancer Research Center.
Charlotte Schubert
From this contributor
Genetic risk factors for autism may affect family size
People who carry risk factors for autism but do not have the condition tend to have slightly fewer children than average, and have them later in life.
Genetic risk factors for autism may affect family size
By
Charlotte Schubert
10 August 2017 | 4 min read
Explore more from The Transmitter
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
Exclusive: Brain and spinal cord institute halts research, citing funding problems
The Burke Neurological Institute, which calls itself “the only research institute in the U.S. dedicated to finding treatments to repair the brain and spinal cord,” ceased research operations on 22 May.
By
Lauren Schenkman
4 June 2026 | 5 min read
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
When autistic kids grow up, Chapter 1: Those people
What leads an autism researcher to publish an intentionally inflammatory paper accusing the NIH of discrimination?
By
Brady Huggett
4 June 2026 | 24 min listen
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read